Looking for a trusted partner to support your preclinical research and drug development programs?

HemoGenix® provides specialized contract research services for pharmaceutical, biotechnology, cell therapy, and regenerative medicine organizations. With over 25 years of experience, HemoGenix® delivers high-quality, predictive in vitro testing solutions that help clients make informed development decisions with confidence.

Our Services

• Hematotoxicity
• Immunotoxicity
• Hepatotoxicity
• Cardiotoxicity
• Neurotoxicity
• Renal Toxicity
• Skin Toxicity
• Intestinal Toxicity
• Mesenchymal Cell Toxicity

Additional Services

• High-Throughput Screening
• Drug Combination & Interaction Studies
• Mechanism of Action Studies
• Potency Testing for Cell Therapies

Why HemoGenix®?

✔ Proprietary in vitro cell-based technologies

✔ Experienced scientific team

✔ Flexible study design and consultation

✔ Data supporting numerous FDA IND submissions

✔ Trusted by biotechnology and pharmaceutical innovators worldwide

Whether you are evaluating a new therapeutic candidate, assessing toxicity, or developing advanced cell therapies, HemoGenix® offers the expertise and scientific rigor to help advance your program.

Contact HemoGenix® today to discuss your project needs and request a customized proposal.